The influence of the addition of 2.3 at.-% Y and of 0.8 at.-% Zr + 0.2 at.-% Y on the properties of TiAl43Nb4Mo1B0.1 (TNM-B1) titanium aluminide alloy is investigated. Energy-dispersive X-ray spectroscopy analysis shows that the Y content of the β, γ, and α2 phases is low, and nearly all of the Y is in the Al2Y phase. The Zr content in the alloy phases is the same as that in alloy. Tensile tests show that Y addition decreases tensile strength and elongation, but only minor effects on these properties are observed after the addition of Zr and Y. It is shown that the addition of Y leads to a decrease in the heat resistance of TiAl43Nb4Mo1B0.1 alloy at 900°C.
Technology for metal and inorganic compounds nanopowders production in DC arc plasma reactors has been developed. Similar DC arc plasma reactors were used for micronsized powders spheroidization. Results of experimental studies are presented. Formation of nanoparticles via different mechanisms as well as mass transfer of nanopowders to the reactor cooling surfaces are discussed. Heat flux distribution along the reactor wall and its influence on the evolution of nanoparticles in the deposited layer are investigated. Effects of plasma torch and confined jet reactor operation parameters on the granulometric, phase and chemical composition of nanopowders are discussed. Potential of the confined plasma jet apparatus for micron-sized metal and composite particles spheroidization is demonstrated.
The possibility of obtaining composite micropowders of the W-C-Co system with a spherical particle shape having a submicron/nanoscale internal structure was experimentally confirmed. In the course of work carried out, W-C-Co system nanopowders with the average particle size of approximately 50 nm were produced by plasma-chemical synthesis. This method resulted in the uniform distribution of W, Co and C among the nanoparticles of the powder in the nanometer scale range. Dense microgranules with an average size of 40 microns were obtained from the nanopowders by spray drying. The spherical micropowders with an average particle size of 20 microns were received as a result of plasma treatment of 25.36 microns microgranule fraction. The spherical particles obtained in the experiments had a predominantly dense microstructure and had no internal cavities. The influence of plasma treatment process parameters on dispersity, phase, and chemical composition of spherical micropowders and powder particles microstructure has been established.
The NiAl–Cr–Co–X alloys were produced by centrifugal self-propagating high-temperature synthesis (SHS) casting. The effects of dopants X = La, Mo, Zr, Ta, and Re on combustion, as well as the phase composition, structure, and properties of the resulting cast alloys, have been studied. The greatest improvement in overall properties was achieved when the alloys were co-doped with 15% Mo and 1.5% Re. By forming a ductile matrix, molybdenum enhanced strength characteristics up to the values σucs = 1604 ± 80 MPa, σys = 1520 ± 80 MPa, and εpd = 0.79%, while annealing at T = 1250 ℃ and t = 180 min improved strength characteristics to the following level: σucs = 1800 ± 80 MPa, σys = 1670 ± 80 MPa, and εpd = 1.58%. Rhenium modified the structure of the alloy and further improved its properties. The mechanical properties of the NiAl, ZrNi5, Ni0.92Ta0.08, (Al,Ta)Ni3, and Al(Re,Ni)3 phases were determined by nanoindentation. The three-level hierarchical structure of the NiAl–Cr–Co+15%Mo alloy was identified. The optimal plasma treatment regime was identified, and narrow-fraction powders (fraction 8–27 µm) characterized by 95% degree of spheroidization and the content of nanosized fraction <5% were obtained.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.